DOI record:
{
"DOI": "10.1016/j.eclinm.2021.101188",
"ISSN": [
"2589-5370"
],
"URL": "http://dx.doi.org/10.1016/j.eclinm.2021.101188",
"alternative-id": [
"S2589537021004697"
],
"article-number": "101188",
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "eClinicalMedicine"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.eclinm.2021.101188"
},
{
"label": "Content Type",
"name": "content_type",
"value": "article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2021 The Author(s). Published by Elsevier Ltd."
}
],
"author": [
{
"affiliation": [],
"family": "Labhardt",
"given": "Niklaus D",
"sequence": "first"
},
{
"affiliation": [],
"family": "Smit",
"given": "Mikaela",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Petignat",
"given": "Ianis",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Perneger",
"given": "Thomas",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Marinosci",
"given": "Annalisa",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Ustero",
"given": "Pilar",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Diniz Ribeiro",
"given": "Maria Pia",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Ragozzino",
"given": "Silvio",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Nicoletti",
"given": "Giovanni Jacopo",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Faré",
"given": "Pietro Benedetto",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Andrey",
"given": "Diego O",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Jacquerioz",
"given": "Frederique",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Lebowitz",
"given": "Dan",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Agoritsas",
"given": "Thomas",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Meyer",
"given": "Benjamin",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Spechbach",
"given": "Hervé",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Salamun",
"given": "Julien",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Guessous",
"given": "Idris",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Chappuis",
"given": "François",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Kaiser",
"given": "Laurent",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Decosterd",
"given": "Laurent Arthur",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Grinsztejn",
"given": "Beatriz",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Bernasconi",
"given": "Enos",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Cardoso",
"given": "Sandra Wagner",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Calmy",
"given": "Alexandra",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Team",
"given": "for the COPEP Study",
"sequence": "additional"
}
],
"container-title": "eClinicalMedicine",
"container-title-short": "eClinicalMedicine",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"thelancet.com",
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2021,
11,
6
]
],
"date-time": "2021-11-06T03:47:34Z",
"timestamp": 1636170454000
},
"deposited": {
"date-parts": [
[
2023,
3,
21
]
],
"date-time": "2023-03-21T14:18:33Z",
"timestamp": 1679408313000
},
"indexed": {
"date-parts": [
[
2024,
8,
16
]
],
"date-time": "2024-08-16T00:51:04Z",
"timestamp": 1723769464803
},
"is-referenced-by-count": 4,
"issued": {
"date-parts": [
[
2021,
12
]
]
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
12,
1
]
],
"date-time": "2021-12-01T00:00:00Z",
"timestamp": 1638316800000
}
},
{
"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2021,
10,
21
]
],
"date-time": "2021-10-21T00:00:00Z",
"timestamp": 1634774400000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S2589537021004697?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S2589537021004697?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"page": "101188",
"prefix": "10.1016",
"published": {
"date-parts": [
[
2021,
12
]
]
},
"published-print": {
"date-parts": [
[
2021,
12
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"key": "10.1016/j.eclinm.2021.101188_bib0001",
"unstructured": "A year without precedent: WHO's COVID-19 response. https://www.who.int/news-room/spotlight/a-year-without-precedent-who-s-covid-19-response (accessed March 16, 2021)."
},
{
"DOI": "10.1016/S1473-3099(20)30471-0",
"article-title": "Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study",
"author": "Jing",
"doi-asserted-by": "crossref",
"first-page": "1141",
"journal-title": "The Lancet Infectious Diseases",
"key": "10.1016/j.eclinm.2021.101188_bib0002",
"volume": "20",
"year": "2020"
},
{
"DOI": "10.1001/jamanetworkopen.2020.31756",
"article-title": "Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis",
"author": "Madewell",
"doi-asserted-by": "crossref",
"journal-title": "JAMA Netw Open",
"key": "10.1016/j.eclinm.2021.101188_bib0003",
"volume": "3",
"year": "2020"
},
{
"DOI": "10.1016/S2468-2667(21)00012-8",
"doi-asserted-by": "crossref",
"key": "10.1016/j.eclinm.2021.101188_bib0004",
"unstructured": "Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. The Lancet Public Health 2021; 0. DOI:10.1016/S2468-2667(21)00012-8."
},
{
"DOI": "10.1016/S0140-6736(20)31558-0",
"article-title": "Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study",
"author": "de",
"doi-asserted-by": "crossref",
"first-page": "898",
"journal-title": "The Lancet",
"key": "10.1016/j.eclinm.2021.101188_bib0005",
"volume": "396",
"year": "2020"
},
{
"article-title": "Reinfection with SARS-CoV-2: Implications for Vaccines",
"author": "Cohen",
"journal-title": "Clin Infect Dis",
"key": "10.1016/j.eclinm.2021.101188_bib0006",
"year": "2020"
},
{
"DOI": "10.1038/d41586-021-00121-z",
"article-title": "Fast-spreading COVID variant can elude immune responses",
"author": "Callaway",
"doi-asserted-by": "crossref",
"first-page": "500",
"journal-title": "Nature",
"key": "10.1016/j.eclinm.2021.101188_bib0007",
"volume": "589",
"year": "2021"
},
{
"article-title": "New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications",
"author": "Abdool Karim",
"issue": "null",
"journal-title": "New England Journal of Medicine",
"key": "10.1016/j.eclinm.2021.101188_bib0008",
"volume": "0",
"year": "2021"
},
{
"DOI": "10.1136/bmj.n1077",
"article-title": "Covid-19: UK launches antivirals taskforce to deliver home treatments by autumn",
"author": "Mahase",
"doi-asserted-by": "crossref",
"first-page": "n1077",
"journal-title": "BMJ",
"key": "10.1016/j.eclinm.2021.101188_bib0009",
"volume": "373",
"year": "2021"
},
{
"article-title": "Regeneron Pharmaceuticals",
"key": "10.1016/j.eclinm.2021.101188_bib0010",
"year": "2021"
},
{
"key": "10.1016/j.eclinm.2021.101188_bib0011",
"unstructured": "Phase 3 Prevention Trial Showed 81% Reduced Risk of Symptomatic SARS-CoV-2 Infections with Subcutaneous Administration of REGEN-COVTM (casirivimab with imdevimab) | Regeneron Pharmaceuticals Inc. https://investor.regeneron.com/news-releases/news-release-details/phase-3-prevention-trial-showed-81-reduced-risk-symptomatic-sars/ (accessed April 19, 2021)."
},
{
"author": "Lilly",
"journal-title": "clinicaltrials.gov",
"key": "10.1016/j.eclinm.2021.101188_bib0012",
"year": "2021"
},
{
"DOI": "10.1056/NEJMoa2016638",
"article-title": "A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19",
"author": "Boulware",
"doi-asserted-by": "crossref",
"first-page": "517",
"journal-title": "N Engl J Med",
"key": "10.1016/j.eclinm.2021.101188_bib0013",
"volume": "383",
"year": "2020"
},
{
"article-title": "Prevention of SARS-CoV-2 (COVID-19) Through Pre-Exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Hydroxychloroquine in Healthcare Personnel: Randomized Clinical Trial Controlled With Placebo",
"journal-title": "clinicaltrials.gov",
"key": "10.1016/j.eclinm.2021.101188_bib0014",
"year": "2020"
},
{
"key": "10.1016/j.eclinm.2021.101188_bib0015",
"unstructured": "Control of COVID-19 Outbreaks in Long Term Care - Tabular View - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/record/NCT04448119 (accessed March 22, 2021)."
},
{
"DOI": "10.1016/j.ijantimicag.2020.106248",
"article-title": "Lower incidence associated with prophylactic administration of ivermectin",
"author": "Hellwig",
"doi-asserted-by": "crossref",
"journal-title": "International Journal of Antimicrobial Agents",
"key": "10.1016/j.eclinm.2021.101188_bib0016",
"volume": "57",
"year": "2021"
},
{
"DOI": "10.1136/bmj.m2980",
"article-title": "Drug treatments for covid-19: living systematic review and network meta-analysis",
"author": "Siemieniuk",
"doi-asserted-by": "crossref",
"first-page": "m2980",
"journal-title": "BMJ",
"key": "10.1016/j.eclinm.2021.101188_bib0017",
"volume": "370",
"year": "2020"
},
{
"DOI": "10.1016/j.cmi.2021.01.013",
"article-title": "Prophylaxis for COVID-19: a systematic review",
"author": "Smit",
"doi-asserted-by": "crossref",
"journal-title": "Clin Microbiol Infect",
"key": "10.1016/j.eclinm.2021.101188_bib0018",
"year": "2021"
},
{
"DOI": "10.1136/bmj.n949",
"article-title": "Prophylaxis against covid-19: living systematic review and network meta-analysis",
"author": "Bartoszko",
"doi-asserted-by": "crossref",
"first-page": "n949",
"journal-title": "BMJ",
"key": "10.1016/j.eclinm.2021.101188_bib0019",
"volume": "373",
"year": "2021"
},
{
"DOI": "10.1016/j.antiviral.2020.104786",
"article-title": "Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro",
"author": "Choy",
"doi-asserted-by": "crossref",
"journal-title": "Antiviral Res",
"key": "10.1016/j.eclinm.2021.101188_bib0020",
"volume": "178",
"year": "2020"
},
{
"DOI": "10.1056/NEJMoa2015294",
"article-title": "Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome",
"author": "Arabi",
"doi-asserted-by": "crossref",
"first-page": "1645",
"journal-title": "New England Journal of Medicine",
"key": "10.1016/j.eclinm.2021.101188_bib0021",
"volume": "383",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)32013-4",
"article-title": "Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial",
"author": "Horby",
"doi-asserted-by": "crossref",
"first-page": "1345",
"journal-title": "The Lancet",
"key": "10.1016/j.eclinm.2021.101188_bib0022",
"volume": "396",
"year": "2020"
},
{
"DOI": "10.1056/NEJMoa2023184",
"article-title": "Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results",
"author": "Solidarity Trial Consortium",
"doi-asserted-by": "crossref",
"first-page": "497",
"journal-title": "N Engl J Med",
"key": "10.1016/j.eclinm.2021.101188_bib0023",
"volume": "384",
"year": "2021"
},
{
"DOI": "10.1056/NEJMoa2001282",
"article-title": "A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19",
"author": "Cao",
"doi-asserted-by": "crossref",
"first-page": "1787",
"journal-title": "New England Journal of Medicine",
"key": "10.1016/j.eclinm.2021.101188_bib0024",
"volume": "382",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)31042-4",
"article-title": "Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial",
"author": "Hung",
"doi-asserted-by": "crossref",
"first-page": "1695",
"journal-title": "The Lancet",
"key": "10.1016/j.eclinm.2021.101188_bib0025",
"volume": "395",
"year": "2020"
},
{
"article-title": "RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis",
"author": "Mehra",
"journal-title": "The Lancet",
"key": "10.1016/j.eclinm.2021.101188_bib0026",
"volume": "0",
"year": "2020"
},
{
"key": "10.1016/j.eclinm.2021.101188_bib0027",
"unstructured": "BAMLANIVIMAB PREVENTS COVID-19 MORBIDITY AND MORTALITY IN NURSING-HOME SETTING. CROI Conference. https://www.croiconference.org/abstract/bamlanivimab-prevents-covid-19-morbidity-and-mortality-in-nursing-home-setting/ (accessed May 4, 2021)."
},
{
"key": "10.1016/j.eclinm.2021.101188_bib0028",
"unstructured": "CASIRIVIMAB WITH IMDEVIMAB ANTIBODY COCKTAIL FOR COVID-19 PREVENTION: INTERIM RESULTS. CROI Conference. https://www.croiconference.org/abstract/casirivimab-with-imdevimab-antibody-cocktail-for-covid-19-prevention-interim-results/ (accessed May 6, 2021)."
},
{
"key": "10.1016/j.eclinm.2021.101188_bib0029",
"unstructured": "REDUCTION IN INFECTIOUS SARS-CoV-2 IN TREATMENT STUDY OF COVID-19 WITH MOLNUPIRAVIR. https://www.croiconference.org/abstract/reduction-in-infectious-sars-cov-2-in-treatment-study-of-covid-19-with-molnupiravir/ (accessed May 6, 2021)."
},
{
"DOI": "10.1002/cpt.2014",
"article-title": "Physiologically-Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS-CoV-2",
"author": "Thakur",
"doi-asserted-by": "crossref",
"first-page": "1176",
"journal-title": "Clin Pharmacol Ther",
"key": "10.1016/j.eclinm.2021.101188_bib0030",
"volume": "108",
"year": "2020"
},
{
"DOI": "10.1186/s13063-021-05134-7",
"article-title": "Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trial",
"author": "Tan",
"doi-asserted-by": "crossref",
"first-page": "224",
"journal-title": "Trials",
"key": "10.1016/j.eclinm.2021.101188_bib0031",
"volume": "22",
"year": "2021"
},
{
"key": "10.1016/j.eclinm.2021.101188_bib0032",
"unstructured": "Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort | PNAS. https://www.pnas.org/content/118/8/e2017962118 (accessed May 6, 2021)."
}
],
"reference-count": 32,
"references-count": 32,
"relation": {},
"resource": {
"primary": {
"URL": "https://linkinghub.elsevier.com/retrieve/pii/S2589537021004697"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"special_numbering": "C",
"subject": [],
"subtitle": [],
"title": "Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy",
"volume": "42"
}
